National Institutes of Health (NIH) - NIDDK
Venture Capital
Part of National Institutes of Health
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is a component of the U.S. National Institutes of Health that funds research and provides SBIR/STTR grants to small businesses developing innovations in diabetes, digestive diseases, kidney diseases, obesity, and related metabolic conditions.
Pre-Seed
Seed
Healthcare
biotechnology
diabetes
digestive disease
kidney disease
metabolic disease
- Headquarters
- Bethesda, United States
- Founded
- 1950
- Website
- niddk.nih.gov
- Total Investments
- 2
- Last Investment
- Jan 2020
- Geographic Focus
- United States
Investment Thesis
Fund early-stage R&D through SBIR (Phase I up to ~$300K; Phase II up to ~$2M) and STTR grants to small U.S. businesses developing products and technologies relevant to diabetes, digestive, kidney, and metabolic diseases with strong commercialization potential.
National Institutes of Health (NIH) - NIDDK is a Venture Capital firm based in Bethesda, United States. It has made 2 investments in Healthcare and biotechnology.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account